Challenges in using opioids to treat pain in persons with substance use disorders
about
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer PainAssociations Between Physical Pain, Pain Management, and Frequency of Nonmedical Prescription Opioid Use Among Young Adults: A Sex-specific Analysis.American Society for Pain Management nursing position statement: pain management in patients with substance use disorders.Geraniin attenuates naloxone-precipitated morphine withdrawal and morphine-induced tolerance in miceChronic pain among homeless persons: characteristics, treatment, and barriers to managementSystematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorderLow use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain.Physical activity and health-related quality of life in chronic low back pain patients: a cross-sectional study.Dependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study.Primary care providers' views on chronic pain management among high-risk patients in safety net settings.Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum.Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.Opioid use in primary care: asking the right questions.Management of chronic noncancer pain in depressed patients.OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk.Prevalence of pain and its socio-demographic and clinical correlates among heroin-dependent patients receiving methadone maintenance treatment.Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations.Caring for patients with opioid use disorder in the hospital.Chronic Pain Among Homeless Persons with Mental Illness.An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.Response: providing relief, avoiding euphoriaBarriers to medical provider support for prescription naloxone as overdose antidote for lay responders.Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain.Patterns of Marijuana Use in a 6-Month Pain Management Sample in the United States.Analgesic tolerance to morphine is regulated by PPARγ.Impact of a chronic pain management pathway on opioid administration and prescribing in an Emergency Department.Prescribers' views and experiences of assessing the appropriateness of prescribed medications in a specialist addiction service.Contextual differences in substance use for rural Appalachian treatment-seeking women.Risks and responsibilities in prescribing opioids for chronic noncancer pain, part 2: best practices.Clinicians' perspective on the use of immunoassay versus definitive laboratory quantitation methodologies for medication monitoring.The Na1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons
P2860
Q26765986-1E3605C9-3E8B-4B83-B18D-85B017EAB554Q30006158-A6B7400B-D811-4F42-A022-2DB3555E32C5Q33662016-7C742AD6-42FA-4E88-9E46-58B7AE5821FBQ33675605-9BA42D03-BE10-4B01-917C-DAF58DE111E5Q33955910-C2CBF76A-7B17-4824-8E9A-62F44E8EA96EQ34644900-034004AC-A8DA-4FC8-A0EA-B65D4252434DQ35168938-2ACBC991-D1F8-4BE3-9AB7-6B35189B7120Q35215640-40CFE8D7-8379-4BB5-A994-A58B743340F0Q36131787-948E1213-270A-4B40-887D-AC060E748340Q36236514-6D8760E7-C424-4E06-96EA-39CD4B4C5568Q36779246-661A24D7-0DC8-4934-BE01-36422720D32BQ37160674-832AC70E-B94B-4B57-8C03-CA5A4CEE3DA7Q37390742-7452122C-BE80-48A0-B603-F463D013DB46Q37420079-63CFAAFB-C58B-4E08-8A9C-69CBB113441EQ37721745-9D137C1C-0F64-46B2-9061-7D1373B7AFA0Q37827449-836ED19A-05D1-423F-B3BA-52A44DFE33A7Q37929505-7A404232-EB0B-4B3A-A936-E7E2F55078BBQ38104745-EB311882-0B52-4554-9202-C153F2C8A33EQ38193927-B71C0197-6DD1-42CF-A14E-38CF5E94615AQ38617900-C583CD05-7815-436A-A46B-11D88AB1E815Q38832250-44C8DB7D-3731-4798-958C-563158129255Q38959340-D8C3D06B-B4D9-4AE0-8704-62DB5A924632Q38972331-ADE51070-FB96-4A74-99F8-B6B012B5924CQ39041424-8F4BA638-3DC1-4826-AA7C-45B49FAEB8DBQ39314171-13F2EB8E-6D31-4BD7-A74C-AB1C5875F67FQ39319481-05086E0B-47BF-42ED-9F0C-9D25926CD16BQ39424322-05D8342A-84EC-42B6-BFF3-2ADFACF71C76Q40489787-F693BEA0-8269-4871-A845-B0EDF346AF14Q43075592-116F2891-BB60-4130-B121-A2676A1C7A4FQ43105759-B3739806-C0FF-4492-B70D-632A0598A9F0Q44351339-B6703F43-8BED-4276-B680-ED5C6001B96FQ45405973-D415AACF-AD25-486C-BE24-6C027DF35743Q46130635-8C44EF89-5653-47B4-9427-DFB59F471333Q51013834-194596DA-08F7-412F-B8A4-1C44D4302FBAQ52305257-3BC26FE6-0A99-4D15-91E8-E8BC400F1E16Q58764681-138C6F8D-5504-48C1-AC93-52BBD87C7701
P2860
Challenges in using opioids to treat pain in persons with substance use disorders
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Challenges in using opioids to treat pain in persons with substance use disorders
@ast
Challenges in using opioids to treat pain in persons with substance use disorders
@en
Challenges in using opioids to treat pain in persons with substance use disorders.
@nl
type
label
Challenges in using opioids to treat pain in persons with substance use disorders
@ast
Challenges in using opioids to treat pain in persons with substance use disorders
@en
Challenges in using opioids to treat pain in persons with substance use disorders.
@nl
prefLabel
Challenges in using opioids to treat pain in persons with substance use disorders
@ast
Challenges in using opioids to treat pain in persons with substance use disorders
@en
Challenges in using opioids to treat pain in persons with substance use disorders.
@nl
P2093
P2860
P356
P1476
Challenges in using opioids to treat pain in persons with substance use disorders
@en
P2093
Kenneth L Kirsh
Seddon R Savage
Steven D Passik
P2860
P356
10.1151/ASCP08424
P577
2008-06-01T00:00:00Z